Wealthtrust Axiom LLC’s Gilead Sciences Inc Position
Does Wealthtrust Axiom LLC own Gilead Sciences Inc (GILD)? Yes — 42.4K shares worth $6M (+1.45% of its 13F portfolio) as of Q1 2026, down from 42.8K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
42.4K
% of Portfolio
+1.45%
Quarters Held
30
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 42.4K | $6M | +1.45% |
| Q4 2025 | 42.8K | $5M | +1.35% |
| Q3 2025 | 43.6K | $5M | +1.30% |
| Q2 2025 | 44.6K | $5M | +1.45% |
| Q1 2025 | 50.8K | $6M | +1.73% |
| Q4 2024 | 51.9K | $5M | +1.43% |
| Q3 2024 | 52.6K | $4M | +1.31% |
| Q2 2024 | 53.1K | $4M | +1.21% |
| Q1 2024 | 53.8K | $4M | +1.27% |
| Q4 2023 | 55.0K | $4M | +1.49% |
| Q3 2023 | 54.9K | $4M | +1.48% |
| Q2 2023 | 55.5K | $4M | +1.42% |
| Q1 2023 | 55.5K | $5M | +1.57% |
| Q4 2022 | 56.3K | $5M | +1.69% |
| Q3 2022 | 59.3K | $4M | +1.40% |
| Q2 2022 | 58.7K | $4M | +1.29% |
| Q1 2022 | 59.5K | $4M | +1.10% |
| Q4 2021 | 59.4K | $4M | +1.38% |
| Q3 2021 | 60.0K | $4M | +1.42% |
| Q2 2021 | 59.4K | $4M | +1.31% |
| Q1 2021 | 50.2K | $3M | +1.10% |
| Q4 2020 | 39.0K | $2M | +0.82% |
| Q3 2020 | 41.4K | $3M | +1.13% |
| Q2 2020 | 54.8K | $4M | +1.85% |
| Q1 2020 | 54.0K | $4M | +1.98% |
| Q4 2019 | 51.5K | $3M | +1.12% |
| Q3 2019 | 28.5K | $2M | +0.64% |
| Q2 2019 | 28.9K | $2M | +0.68% |
| Q1 2019 | 21.6K | $1M | +0.50% |
| Q4 2018 | 19.7K | $1M | +0.50% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wealthtrust Axiom LLC’s full portfolio or all institutional holders of GILD.